BUGWORKS Research
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
13962 Pierce Rd, Saratoga, California, 9...Phone Number
(818) 230-2227Website
www.bugworksresearch.comRevenue
$10 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About BUGWORKS Research
Founded in 2014 and headquartered in Saratoga, California, Bugworks is developing a novel class of broad-spectrum antibacterial agents and immunotherapies to treat patients with critical care needs in infection and cancer.Explore more
BUGWORKS Research Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BUGWORKS Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if BUGWORKS Research has recently received funding, and reach out quickly before it becomes old news!
Check out if BUGWORKS Research is spiking on competitors!
BUGWORKS Research, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when BUGWORKS Research launches new products
Congratulate Masked Content for being promoted to Masked Content at BUGWORKS Research
Funding: Get notified immidiatlly once BUGWORKS Research has new funding data
Earning: See what the market has to say on BUGWORKS Research recently announced quarterly report
Click to see if BUGWORKS Research had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at BUGWORKS Research
Find 3 more new buyers
Compare Similar Companies to BUGWORKS Research
Compare insights from companies similar to BUGWORKS Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BUGWORKS Research is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BUGWORKS Research is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BUGWORKS Research.
BUGWORKS Research financials insights
Gather financial insights about BUGWORKS Research, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$1.6M
2020
Other Financing Round
$7.5M
2022
Series B
$18M
BUGWORKS Research Tech Stack
A closer look at the technologies used by BUGWORKS Research
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
BUGWORKS Research News & Media
Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark
BANGALORE, India and DELAWARE CITY, Del. and ADELAIDE, Australia, April 17, 2023 /PRNewswire/ -- Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark. The eight posters highlight data from the microbiological and efficacy studies of the clinical candidate, BWC0977Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board
Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 22, 2023 /PRNewswire/...Bugworks Research Inc. and Cytecare Cancer Hospitals announce collaboration to accelerate the development of cutting-edge Immuno-oncology therapies
Bugworks - a US, India and Australia based start-up with globally recognized expertise in drug discovery, has set up a dedicated Immuno-oncology ex vivo research lab at the Bengaluru-based hospital, Cytecare. The lab bridges the translation from discovery to development, addressing...Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India
This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO) BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 9, 2022 /PRNewswire/ -- Bugworks Research, a clinical stage multi-indication therapeutics company, today announced the financing of US$18M Series B1. This round will support the clinical development of BWC0977, a novel broad spectrum anti-bacterial agent available in both IV and Oral forms, and the pre
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding BUGWORKS Research
Sign Up For FreeTo access detailed company insights
Founded in 2014 and headquartered in Saratoga, California, Bugworks is developing a novel class of broad-spectrum antibacterial agents and immunotherapies to treat patients with critical care needs in infection and cancer.... Read More
